Real-World Management of AEs with ALK Inhibitors

Opinion
Video

Medical experts compare the adverse event profile of lorlatinib to other ALK inhibitors like alectinib and brigatinib, discussing unique challenges and benefits observed in clinical practice.

Video content above is prompted by the following:

  • Based on your experience, how does the adverse event profile of lorlatinib compare to those of other ALK inhibitors like alectinib or brigatinib?
  • Are there any unique challenges or benefits you've observed?
Recent Videos
Smiling woman in front of a blue video call background with logos that say "All in Against Cancer" and "Ochsner Health" above her
Man standing in front of Oncology Nursing News-branded backdrop
Image of a woman in an office, taken as a screenshot from the video interview
woman in front of a dark blue background for Oschner Health
Related Content